Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Gene Rank description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2430 to 2479 of 6456 in total 
Value Type: Ranked
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1215\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peptidyl-prolyl cis-trans isomerase e (ec 5.2.1.8) (ppiase e) (rotamase e) (cyclophilin e) (cyclophilin 33). [source:swissprot;acc:q9unp9]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
174.387\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
179.697\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
5.31\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1216\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
coatomer zeta-2 subunit (zeta-2 coat protein) (zeta-2 cop). [source:swissprot;acc:q9p299]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
retinoic acid induced 17; pias-like protein hzimp10. [source:refseq;acc:nm\_020338]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.269\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.918\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02513\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1217\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
glutaminyl-trna synthase (glutamine-hydrolyzing)-like 1. [source:refseq;acc:nm\_018292]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
211.959\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.258\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.025\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
hyaluronan synthase 2 (ec 2.4.1.212) (hyaluronate synthase 2) (hyaluronic acid synthase 2) (ha synthase 2). [source:swissprot;acc:q92819]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.093\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
226.399\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.306\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1218\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
fatty-acid amide hydrolase (ec 3.1.-.-) (oleamide hydrolase) (anandamide amidohydrolase). [source:swissprot;acc:o00519]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.959\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.258\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.025\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
hyaluronan synthase 1 (ec 2.4.1.212) (hyaluronate synthase 1) (hyaluronic acid synthase 1) (ha synthase 1) (huhas1). [source:swissprot;acc:q92839]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.093\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
226.399\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.306\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1219\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
coactosin-like protein. [source:swissprot;acc:q14019]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.959\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.258\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.025\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
hyaluronan synthase 3 (ec 2.4.1.212) (hyaluronate synthase 3) (hyaluronic acid synthase 3) (ha synthase 3). [source:swissprot;acc:o00219]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.093\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
226.399\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.306\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1220\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
glutaminyl-trna synthase (glutamine-hydrolyzing)-like 1. [source:refseq;acc:nm\_018292]\vspace{3pt}}&&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
211.959\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
217.258\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.299\vspace{3pt}}\\\cline{2-3}\cline{6-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
uracil-dna glycosylase, mitochondrial precursor (ec 3.2.2.-) (udg). [source:swissprot;acc:p13051]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
1.025\vspace{3pt}}\\\cline{1-3}\cline{6-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1221\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
fatty-acid amide hydrolase (ec 3.1.-.-) (oleamide hydrolase) (anandamide amidohydrolase). [source:swissprot;acc:o00519]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
5.299\vspace{3pt}}\\\cline{2-3}\cline{6-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
probable glutamyl-trna(gln) amidotransferase subunit b, mitochondrial precursor (ec 6.3.5.-) (glu-adt subunit b) (cytochrome oxidase assembly factor pet112 homolog). [source:swissprot;acc:o75879]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
1.025\vspace{3pt}}\\\cline{1-3}\cline{6-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1222\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
coactosin-like protein. [source:swissprot;acc:q14019]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
5.299\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tumor protein d53 (hd53) (d52-like 1). [source:swissprot;acc:q16890]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.774\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.936\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02496\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1223\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
tumor protein d52 (n8 protein). [source:swissprot;acc:p55327]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
206.771\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.926\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02493\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
uracil-dna glycosylase, mitochondrial precursor (ec 3.2.2.-) (udg). [source:swissprot;acc:p13051]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.959\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.258\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.299\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1224\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
folylpolyglutamate synthase, mitochondrial precursor (ec 6.3.2.17) (folylpoly-gamma-glutamate synthetase) (fpgs). [source:swissprot;acc:q05932]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.906\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
231.524\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02487\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
probable glutamyl-trna(gln) amidotransferase subunit b, mitochondrial precursor (ec 6.3.5.-) (glu-adt subunit b) (cytochrome oxidase assembly factor pet112 homolog). [source:swissprot;acc:o75879]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.959\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.258\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.299\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1225\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
interleukin-4 induced protein 1 precursor (fig-1 protein). [source:swissprot;acc:q96rq9]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
219.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.288\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.262\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-conjugating enzyme e2 e1 (ec 6.3.2.19) (ubiquitin-protein ligase e1) (ubiquitin carrier protein e1) (ubch6). [source:swissprot;acc:p51965]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
166.846\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
170.989\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02483\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1226\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adrenodoxin, mitochondrial precursor (adrenal ferredoxin) (hepatoredoxin) (ferredoxin 1). [source:swissprot;acc:p10109]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
191.139\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
185.882\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.257\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-conjugating enzyme e2e 3; ubiquitin carrier protein; ubiquitin-protein ligase. [source:refseq;acc:nm\_006357]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
166.846\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
170.989\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02483\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1227\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
glutamate--cysteine ligase regulatory subunit (ec 6.3.2.2) (gamma- glutamylcysteine synthetase) (gamma-ecs) (gcs light chain) (glutamate--cysteine ligase modifier subunit). [source:swissprot;acc:p48507]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.079\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.325\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.246\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pyrroline 5-carboxylate reductase isoform. [source:refseq;acc:nm\_013328]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
172.365\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
168.219\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02465\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1228\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
glutamate--cysteine ligase catalytic subunit (ec 6.3.2.2) (gamma- glutamylcysteine synthetase) (gamma-ecs) (gcs heavy chain). [source:swissprot;acc:p48506]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
213.079\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
218.325\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.246\vspace{3pt}}\\\cline{2-3}\cline{6-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
glutamate--cysteine ligase regulatory subunit (ec 6.3.2.2) (gamma- glutamylcysteine synthetase) (gamma-ecs) (gcs light chain) (glutamate--cysteine ligase modifier subunit). [source:swissprot;acc:p48507]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&&&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.02462\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1229\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
glutamate--cysteine ligase catalytic subunit (ec 6.3.2.2) (gamma- glutamylcysteine synthetase) (gamma-ecs) (gcs heavy chain). [source:swissprot;acc:p48506]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
integral membrane protein cii-3b. [source:sptrembl;acc:o75609]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.646\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.891\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.245\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1230\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
interleukin-4 induced protein 1 precursor (fig-1 protein). [source:swissprot;acc:q96rq9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.288\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02456\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
succinate dehydrogenase cytochrome b560 subunit, mitochondrial precursor (integral membrane protein cii-3) (qps1) (qps-1) (succinate dehydrogenase complex subunit c) (succinate-ubiquinone oxidoreductase cytochrome b large subunit) (cybl). [source:swissprot;acc:q99643]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.644\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.888\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.244\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1231\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
putative phosphoglycerate mutase 3 (ec 5.4.2.1) (ec 5.4.2.4) (ec 3.1.3.13). [source:swissprot;acc:q8n0y7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.724\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
207.637\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0245\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
succinate dehydrogenase [ubiquinone] iron-sulfur protein, mitochondrial precursor (ec 1.3.5.1) (ip) (iron-sulfur subunit of complex ii). [source:swissprot;acc:p21912]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.931\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.175\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.244\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1232\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
alpha-1-acid glycoprotein 2 precursor (agp 2) (orosomucoid 2) (omd 2). [source:swissprot;acc:p19652]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
209.649\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.406\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.243\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pyrroline-5-carboxylate reductase (ec 1.5.1.2) (p5cr) (p5c reductase). [source:swissprot;acc:p32322]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
172.543\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
168.417\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0245\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1233\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphoglycerate mutase 1 (ec 5.4.2.1) (ec 5.4.2.4) (ec 3.1.3.13) (phosphoglycerate mutase isozyme b) (pgam-b) (bpg-dependent pgam 1). [source:swissprot;acc:p18669]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
212.724\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
207.637\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
septin 1 (larp) (serologically defined breast cancer antigen ny-br- 24). [source:swissprot;acc:q8wyj6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
142.077\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
136.846\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.231\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1234\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphoglycerate mutase 2 (ec 5.4.2.1) (ec 5.4.2.4) (ec 3.1.3.13) (phosphoglycerate mutase isozyme m) (pgam-m) (bpg-dependent pgam 2) (muscle-specific phosphoglycerate mutase). [source:swissprot;acc:p15259]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.724\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
207.637\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0245\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin. [source:swissprot;acc:p02248]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
209.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.372\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.228\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1235\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
coatomer alpha subunit (alpha-coat protein) (alpha-cop) (hepcop) (hep-cop) [contains: xenin (xenopsin-related peptide); proxenin]. [source:swissprot;acc:p53621]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
177.432\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
182.647\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.215\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
keratin associated protein 9-4; keratin associated protein 9.4. [source:refseq;acc:nm\_033191]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.356\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.723\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02447\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1236\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
keratin associated protein 4-10; keratin associated protein 4.10. [source:refseq;acc:nm\_033060]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
219.354\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.699\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02437\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
prefoldin subunit 3 (von hippel-lindau binding protein 1) (vhl binding protein-1) (vbp-1) (hibbj46). [source:swissprot;acc:q15765]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
226.439\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.26\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.179\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1237\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
keratin associated protein 4-2; keratin associated protein 4.2. [source:refseq;acc:nm\_033062]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.354\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.699\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02437\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
prefoldin subunit 2 (hspc231). [source:swissprot;acc:q9uhv9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
226.439\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.26\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.179\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1238\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
keratin associated protein 4.3 (fragment). [source:sptrembl;acc:q9byr4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.354\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.699\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02437\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
uxt protein (ubiquitously expressed transcript protein) (hspc024). [source:swissprot;acc:q9ubk9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
226.439\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.26\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.179\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1239\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
keratin associated protein 2-4; keratin associated protein 2.4. [source:refseq;acc:nm\_033184]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.354\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.699\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02437\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
signal transducer and activator of transcription 4. [source:swissprot;acc:q14765]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.573\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
227.751\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.178\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1240\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
keratin associated protein 4-14; keratin associated protein 4.14. [source:refseq;acc:nm\_033059]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.354\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02437\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/